scholarly journals Awareness of General Practitioners concerning cancer patients’ preferences for place of death: Evidence from four European countries

2013 ◽  
Vol 49 (8) ◽  
pp. 1967-1974 ◽  
Author(s):  
Winne Ko ◽  
Monica Beccaro ◽  
Guido Miccinesi ◽  
Viviane Van Casteren ◽  
Gé A. Donker ◽  
...  
Keyword(s):  
Cancer Patients ◽  
General Practitioners ◽  
European Countries ◽  
Place Of Death

scholarly journals Exploring the role of general practitioners in addressing financial toxicity in cancer patients

2021 ◽  
Author(s):  
Carla Thamm ◽  
Jennifer Fox ◽  
Nicolas H. Hart ◽  
Joel Rhee ◽  
Bogda Koczwara ◽  
...  
Keyword(s):  
Cancer Patients ◽  
General Practitioners ◽  
Financial Toxicity

scholarly journals Actual and Preferred Place of Death of Home-Dwelling Patients in Four European Countries: Making Sense of Quality Indicators

PLoS ONE ◽  
2014 ◽  
Vol 9 (4) ◽  
pp. e93762 ◽  
Author(s):  
Maaike L. De Roo ◽  
Guido Miccinesi ◽  
Bregje D. Onwuteaka-Philipsen ◽  
Nele Van Den Noortgate ◽  
Lieve Van den Block ◽  
...  
Keyword(s):  
Quality Indicators ◽  
European Countries ◽  
Place Of Death ◽  
Making Sense

Propensity for paying home visits among general practitioners and the associations with cancer patients’ place of care and death: a register-based cohort study

2017 ◽  
Vol 32 (2) ◽  
pp. 376-383 ◽  
Author(s):  
Anna K Winthereik ◽  
Peter Hjertholm ◽  
Mette Asbjoern Neergaard ◽  
Anders Bonde Jensen ◽  
Peter Vedsted
Keyword(s):  
Cohort Study ◽  
Cancer Patients ◽  
General Practitioners ◽  
Home Visits

scholarly journals Biomarker testing and mutation prevalence in metastatic colorectal cancer patients in five European countries using a large oncology database

2021 ◽  
Author(s):  
George Kafatos ◽  
Victoria Banks ◽  
Peter Burdon ◽  
David Neasham ◽  
Caroline Anger ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Clinical Practice ◽  
Metastatic Colorectal Cancer ◽  
Cancer Patients ◽  
Braf Mutation ◽  
European Countries ◽  
High Prevalence ◽  
Biomarker Testing ◽  
Colorectal Cancer Patients ◽  
Over Time

Background: The literature on biomarker testing for metastatic colorectal cancer (mCRC) in Europe is scarce. This study aimed to estimate the percentage of mCRC patients from five European countries tested for biomarkers over time. Materials & methods: An oncology database was retrospectively analyzed; evaluated biomarkers were RAS, BRAF and microsatellite instability (MSI). The patients were drug treated during 2018 and tested for relevant biomarkers in 2013–2018. Results: RAS testing was conducted in >90% of mCRC patients from 2014 onwards. BRAF testing increased from 31% of mCRC patients in 2013 to 67% in 2018. MSI testing increased from 10 to 41%. There was no notable trend over time for RAS and BRAF mutation or MSI-high prevalence. Conclusion: Biomarker testing among patients diagnosed with mCRC was increased over time. This study demonstrates the quick uptake of biomarker testing in clinical practice. These findings are significant as biomarker-based drugs are becoming more common.

Place of death of cancer patients in Israel: the experience of a 'home-care programme'

1990 ◽  
Vol 4 (4) ◽  
pp. 299-304 ◽  
Author(s):  
David Loven ◽  
Efrat Goldberg ◽  
Yaakov Hart ◽  
Baruch Klein
Keyword(s):  
Home Care ◽  
Cancer Patients ◽  
Place Of Death ◽  
Care Programme

scholarly journals Predicting Place of Death of Elderly Cancer Patients Followed by a Palliative Care Unit

2001 ◽  
Vol 21 (6) ◽  
pp. 481-490 ◽  
Author(s):  
Anna Maria Izquierdo-Porrera ◽  
Jordi Trelis-Navarro ◽  
Xavier Gómez-Batiste
Keyword(s):  
Palliative Care ◽  
Cancer Patients ◽  
Palliative Care Unit ◽  
Place Of Death ◽  
Elderly Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document